Skip to main content
Clinical Trials/KCT0005729
KCT0005729
Recruiting
未知

A clinical study to evaluate the intrapulmonary pharmacokinetics of vancomycin and to explore biomarkers for nephrotoxicity in critically ill patients with pneumonia

Kyung Hee University Hospital0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyung Hee University Hospital
Enrollment
24
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Kyung Hee University Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) 19 years of age or older
  • 2\) Patient has provided written informed consent or informed consent has been provided by the patient's legally authorized representative
  • 3\) Patient has a suitability for the administration of vancomycin as a clinical manifestation
  • 4\) Patient has suspicion or diagnosis of bacterial pneumonia
  • 5\) Patient has a requirement for the collection of BALF for diagnosis/treatment

Exclusion Criteria

  • 1\) Patient has a history of any shock or hypersensitivity against the investigational product or aminoglycoside antibiotics
  • 2\) Patient has contraindications and/or precautions to investigational product (who have an underlying hearing loss, who are receiving concomitant therapy with another ototoxic agent, such as aminoglycosides or peptide antibiotics, who have vestibular and/or cochlear injury)
  • 3\) Imminent death within 48 hours
  • 4\) Pregnant or breastfeeding women
  • 5\) Patients has contraindications to bronchoalveolar lavage
  • 6\) Patients has hypersensitivity to medications associated with the bronchoalveolar lavage procedures, such as local anesthetics, sedatives, pain control medications
  • 7\) Patient has a requirement for extracorporeal membrane oxygenation(ECMO) therapy
  • 8\) Patient has a requirement for renal replacement therapy
  • 9\) Patient has renal insufficiency as evidenced by an estimated creatinine clearance \<50 mL/min based on the Cockcroft\-Gault formula
  • 10\) Patient has comorbidities influencing vancomycin pharmacokinetics as the following

Outcomes

Primary Outcomes

Not specified

Similar Trials